Six active compounds, among previously synthesized and screened arylpiperazines, were selected and evaluated for the binding affinity to rat dopamine, serotonin and α 1 receptors. Two compounds with benztriazole group had a 5-HT 2A /D 2 binding ratio characteristic for atypical neuroleptics (>1, pK i values). Compound 2, 5-{2-[4-(2,3-dimethyl-phenyl)-piperazin-1-yl]ethyl}1H-benzotriazole, expressed clozapine-like in vitro binding profile at D 2 , 5-HT 2A and α1 receptors and a higher affinity for 5-HT 1A receptors than clozapine. Also, it exhibited the noncataleptic behavioural pattern of atypical antipsychotics and antagonized d-amphetamine-induced hyperlocomotion in rats. © 2004 Elsevier Ltd. All rights reserved.
CITATION STYLE
Tomić, M., Kundaković, M., Butorović, B., Janać, B., Andrić, D., Roglić, G., … Kostić-Rajačić, S. (2004). Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential. Bioorganic and Medicinal Chemistry Letters, 14(16), 4263–4266. https://doi.org/10.1016/j.bmcl.2004.06.005
Mendeley helps you to discover research relevant for your work.